{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:59:45Z","timestamp":1762869585938,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006489","name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","doi-asserted-by":"publisher","award":["AFOCUS080201"],"award-info":[{"award-number":["AFOCUS080201"]}],"id":[{"id":"10.13039\/501100006489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-11-LABX-0015"],"award-info":[{"award-number":["ANR-11-LABX-0015"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117203","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T04:14:52Z","timestamp":1754367292000},"page":"117203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P3","title":["Cyanine 5-huwentoxin-IV as a novel imaging probe to detect hNav1.7 channel overexpressed in non-small cell lung cancer"],"prefix":"10.1016","volume":"242","author":[{"given":"Romain","family":"Baudat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Montnach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Zoukimian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Carvalhosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9my","family":"B\u00e9roud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel De","family":"Waard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Servent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117203_b0005","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.18632\/aging.202504","article-title":"Early diagnosis of lung cancer: which is the optimal choice?","volume":"13","author":"Ning","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2025.117203_b0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1590\/S1806-37132015000004479","article-title":"PET\/CT imaging in lung cancer: indications and findings","volume":"41","author":"Hochhegger","year":"2015","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.bcp.2025.117203_b0015","series-title":"Transportome Malfunction in the Cancer Spectrum","first-page":"57","article-title":"Ion channels in lung cancer","author":"Bulk","year":"2020"},{"key":"10.1016\/j.bcp.2025.117203_b0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1152\/physrev.00044.2016","article-title":"Ion channels in cancer: are cancer hallmarks oncochannelopathies?","volume":"98","author":"Prevarskaya","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2025.117203_b0025","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/cancers7020813","article-title":"Voltage-gated ion channels in cancer cell proliferation","volume":"7","author":"Rao","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.117203_b0030","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/19336950.2019.1666455","article-title":"Voltage gated sodium channels in cancer and their potential mechanisms of action","volume":"13","author":"Angus","year":"2019","journal-title":"Channels"},{"key":"10.1016\/j.bcp.2025.117203_b0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/pros.1095","article-title":"Expression profiles of voltage-gated Na(+) channel alpha-subunit genes in rat and human prostate cancer cell lines","volume":"48","author":"Diss","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2025.117203_b0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.pcan.4500796","article-title":"A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo","volume":"8","author":"Diss","year":"2005","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.bcp.2025.117203_b0045","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jcp.20871","article-title":"Functional expression of voltage-gated sodium channels in primary cultures of human cervical cancer","volume":"210","author":"Diaz","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2025.117203_b0050","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.7150\/jca.31544","article-title":"The voltage-gated sodium channel NaV1.7 associated with endometrial cancer","volume":"10","author":"Liu","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.bcp.2025.117203_b0055","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1002\/ijc.30381","article-title":"Voltage-gated sodium channel NaV1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1","author":"Xia","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bcp.2025.117203_b0060","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3390\/cancers15102806","article-title":"Voltage-gated sodium channel NaV1.7 inhibitors with potent anticancer activities in medullary thyroid cancer cells","volume":"15","author":"Pukkanasut","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bcp.2025.117203_b0065","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.biocel.2006.12.007","article-title":"Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines","volume":"39","author":"Roger","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117203_b0070","doi-asserted-by":"crossref","first-page":"8680","DOI":"10.1074\/jbc.M806891200","article-title":"Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells","volume":"284","author":"Gillet","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117203_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1206136","article-title":"Voltage-gated sodium channels: from roles and mechanisms in the metastatic cell behavior to clinical potential as therapeutic targets","volume":"14","author":"Sanchez-Sandoval","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117203_b0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.addr.2016.06.007","article-title":"Peptide-based imaging agents for cancer detection","volume":"110\u2013111","author":"Sun","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bcp.2025.117203_b0085","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2007.12.7431","article-title":"Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors","volume":"26","author":"Asnacios","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117203_b0090","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1378\/chest.117.5.1232","article-title":"A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules","volume":"117","author":"Blum","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.bcp.2025.117203_b0095","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bcp.2025.117203_b0100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(89)91258-0","article-title":"Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin","volume":"1","author":"Krenning","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2025.117203_b0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/pharmaceutics13040481","article-title":"Peptide-based strategies for targeted tumor treatment and imaging","volume":"13","author":"Ayo","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117203_b0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/toxins16070307","article-title":"Shining a light on venom-peptide receptors: venom peptides as targeted agents for in vivo molecular imaging","volume":"16","author":"Chow","year":"2024","journal-title":"Toxins (basel)"},{"key":"10.1016\/j.bcp.2025.117203_b0115","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.3390\/biomedicines10102605","article-title":"A conjugate between Lqh-8\/6, a natural peptide analogue of chlorotoxin, and doxorubicin efficiently induces glioma cell death","volume":"10","author":"Dardevet","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2025.117203_b0120","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/jm101018r","article-title":"Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy","volume":"54","author":"Akcan","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117203_b0125","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/toxins7041079","article-title":"Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion","volume":"7","author":"Dardevet","year":"2015","journal-title":"Toxins (basel)"},{"key":"10.1016\/j.bcp.2025.117203_b0130","first-page":"580","article-title":"Imaging glioma extent with 131I-TM-601","volume":"46","author":"Hockaday","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bcp.2025.117203_b0135","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1039\/D0CC01089H","article-title":"Chlorotoxin-derived bicyclic peptides for targeted imaging of glioblastomas","volume":"56","author":"Li","year":"2020","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.bcp.2025.117203_b0140","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2005.05.4569","article-title":"Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma","volume":"24","author":"Mamelak","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2025.117203_b0145","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117203_b0150","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1111\/bph.15453","article-title":"Fluorescent- and tagged-protoxin II peptides: potent markers of the NaV1.7 channel pain target","volume":"178","author":"Montnach","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117203_b0155","doi-asserted-by":"crossref","unstructured":"J. Gonzales, P.D. de S. Franca, Y. Jiang, G. Pirovano, S. Kossatz, N. Guru, D. Yarilin, A.J. Agwa, C.I. Schroeder, S.G. Patel, I. Ganly, G.F. King, T. Reiner, Fluorescence imaging of peripheral nerves by a NaV1.7-targeted inhibitor cystine knot peptide, Bioconjugate Chem 30 (2019) 2879. https:\/\/doi.org\/10.1021\/acs.bioconjchem.9b00612.","DOI":"10.1021\/acs.bioconjchem.9b00612"},{"key":"10.1016\/j.bcp.2025.117203_b0160","doi-asserted-by":"crossref","first-page":"14276","DOI":"10.1021\/jacs.3c02520","article-title":"Development and validation of nerve-targeted bacteriochlorin sensors","volume":"145","author":"Hern\u00e1ndez-Gil","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bcp.2025.117203_b0165","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3389\/fphar.2018.01000","article-title":"The NaV1.7 channel subtype as an antinociceptive target for spider toxins in adult dorsal root ganglia neurons","volume":"9","author":"Gon\u00e7alves","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117203_b0170","doi-asserted-by":"crossref","first-page":"47564","DOI":"10.1074\/jbc.M204063200","article-title":"Function and solution structure of huwentoxin-IV, a potent neuronal tetrodotoxin (TTX)-sensitive sodium channel antagonist from chinese bird spider Selenocosmia huwena","volume":"277","author":"Peng","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117203_b0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molcel.2020.10.039","article-title":"Structural basis for high-affinity trapping of the NaV1.7 channel in its resting state by Tarantula toxin","volume":"81","author":"Wisedchaisri","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcp.2025.117203_b0180","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/mol.110.066332","article-title":"The Tarantula toxins ProTx-II and huwentoxin-IV differentially interact with human NaV1.7 voltage sensors to inhibit channel activation and inactivation","volume":"78","author":"Xiao","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117203_b0185","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.130013","article-title":"Functional expression of the voltage-gated sodium channel, NaV1.7, underlies epidermal growth factor-mediated invasion in human [R1.S1] non-small cell lung cancer cells","author":"Campbell","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2025.117203_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1283623","article-title":"Ion channels in lung cancer: Biological and clinical relevance","volume":"14","author":"Capitani","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117203_b0195","doi-asserted-by":"crossref","unstructured":"J. Gonzales, D. Adilbay, P.D. de Souza Franca, R. Artschwager, C.Y. Chow, T. Viray, D.S. Johnson, Y. Jiang, S.G. Patel, I. Ganly, C.I. Schroeder, J.S. Lewis, G.F. King, T. Reiner, N. Pillarsetty, NaV1.7 targeted fluorescence imaging agents for nerve identification during intraoperative procedures, bioRxiv (2024) 2024.04.06.588368. https:\/\/doi.org\/10.1101\/2024.04.06.588368.","DOI":"10.1101\/2024.04.06.588368"},{"key":"10.1016\/j.bcp.2025.117203_b0200","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.aaw2493","article-title":"Structures of human Nav1.7 channel in complex with auxiliary subunits and animal toxins","volume":"363","author":"Shen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117203_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.798588","article-title":"Synthetic analogues of huwentoxin-IV spider peptide with altered human NaV1.7\/NaV1.6 selectivity ratios","volume":"9","author":"Lopez","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2025.117203_b0210","doi-asserted-by":"crossref","first-page":"22707","DOI":"10.1074\/jbc.M113.461392","article-title":"Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (\u03bc-TRTX-Hh2a)","volume":"288","author":"Minassian","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117203_b0215","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1074\/jbc.RA118.002553","article-title":"Gating modifier toxins isolated from spider venom: modulation of voltage-gated sodium channels and the role of lipid membranes","volume":"293","author":"Agwa","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117203_b0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/toxins9080248","article-title":"Lengths of the C-terminus and interconnecting loops impact stability of spider-derived gating modifier toxins","volume":"9","author":"Agwa","year":"2017","journal-title":"Toxins (basel)"},{"key":"10.1016\/j.bcp.2025.117203_b0225","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1074\/jbc.M412552200","article-title":"Differential phospholipid binding by site 3 and site 4 toxins implications for structural variability between voltage-sensitive sodium channel domains","volume":"280","author":"Smith","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117203_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1566312","article-title":"The venom of Cyriopagopus schmidti spider contains a natural huwentoxin-IV analogue with unexpected improved analgesic potential","volume":"16","author":"Antunes","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117203_b0235","doi-asserted-by":"crossref","unstructured":"J. Gonzales, G. Pirovano, C.Y. Chow, P.D. de S. Franca, L.M. Carter, J.K. Klint, N. Guru, J.S. Lewis, G.F. King, T. Reiner, Fluorescence labeling of a NaV1.7-targeted peptide for near-infrared nerve visualization, EJNMMI Res 10 (2020) 49. https:\/\/doi.org\/10.1186\/s13550-020-00630-4.","DOI":"10.1186\/s13550-020-00630-4"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500468X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500468X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T22:31:09Z","timestamp":1761777069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500468X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S000629522500468X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117203","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyanine 5-huwentoxin-IV as a novel imaging probe to detect hNav1.7 channel overexpressed in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117203"}}